Pan-Amyloid PET/CT in Various Amyloid-Related Disease

Abroad (travel likely)Recruiting

Conditions

Amyloid · Cardiac Amyloidosis · Amyloidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of University of Science and Technology of China, Hefei, Anhui, China
Contact: Study coordinator (Qiang Xie, PhD) · ahxq1980@163.com · +8613721108043
Tianjin Medical University General Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Haonan Yu, MD) · dreamadam@126.com · +862260362190

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Cognitive Dysfunction · Lewy Body Disease · Synucleinopathies

Abroad (travel likely)RecruitingPHASE2

Chandler, United States · Scottsdale, United States

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

AL Amyloidosis · Amyloidosis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Nashville, United States · Dallas, United States

Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure

Cardiac Amyloidosis

Abroad (travel likely)Recruiting

Paris, France · Nantes, France

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)

Amyloidosis

Abroad (travel likely)RecruitingPHASE3

Beijing, China